High fat diet induced insulin resistance and elevated retinol binding protein 4 in female rats; treatment and protection with Berberis vulgaris extract and vitamin A

Pakistan Journal of Pharmaceutical Sciences

Volumn 26, Issue 6, 2013, Pages 1189-1195

  El Sayed, Mohamed Mohammed ^a   Ghareeb, Doaa Ahmad ^a   Talat, Heba Allah ^a   Sarhan, Eman Mohammed ^b  

^a Alexandria University Faculty Of Science   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Berberis vulgaris; Diabetes; Insulin resistance; Obesity; Retinol binding protein 4; Vitamin A

Indexed keywords

BERBERIS VULGARIS PLANT EXTRACT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; PROTECTIVE AGENT; RETINOL; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BERBERIS; BERBERIS VULGARIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; LOW FAT DIET; NONHUMAN; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMAL FEED; ANIMALS; BERBERIS; DIET, HIGH-FAT; FEMALE; INSULIN; INSULIN RESISTANCE; LIPIDS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RETINOL-BINDING PROTEINS, PLASMA; VITAMIN A;

EID: 84892607255     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Anna T, Nigel C, Micheal F, Martin W and Gearge M (1997). Serum concentration of vitamin A and E impaired glucose tolerance. Clinca. Chemica. Acta., 226:129-140.
2. National Institute of Health (1996). Institute of Laboratory Animal Resources. Guide for the care and use of laboratory animals. Commission on Life Sciences, National Research Council. National Academy, Press, Washington, D.
3. Astrup A and Finer N (2000). Redefining type 2 diabetes: 'diabesity' or obesity dependent diabetes mellitus. Obes. Rev., 1:57-59.
4. Barbara M, Janja M, Andrej J and Marija P (2007). Molecular mechanisms of insulin resistance and association diseases. Clinica. Chimica. Acta., 375:20-35.
5. Basciano H, Federico L and Adeli K (2005). Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metabo., 2:5-11
6. Bernard AM, Moreau D and Lauwerys RR (1982). Latex immunoassay of retinol binding protein. Clin. Chem., 28:1167-1171.
7. Beverly J, Youn-Kying K, Varsha S, Elena S and Ioredane Q (2010). Serum retinol binding protein 4 and ratinal in cohort of border line obese women with and without GDM. Clini. Biochem., 43:320-323.
8. Chenhui Z and Jiahua S (2008). Role of adipokinase in obesity associated insulin resistance. J. Nut. Biochem., 19:277-286.
9. Ekoe JM, Zimmet P and Williams R (2001). In: The Epidemiology of Diabetes Mellitus. John Wiley and Sons, USA, pp. 210-211.
10. El Sayed M, Ghareeb D, Sarhan E and Khalil A (2011). Therapeutic Bio-screening of the Bioactive Ingredients of Berberis vulgaris. FPSB., 5(1):63-68.
11. Fossati PL (1982). Triglyceride determination calorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem., 28:2077-2080.
12. Friedewald WT, Levy RI and Fredrickson DS (1972). Estimation of the concentration of LDL cholesterol in plasma, without use of the preparative ultracenterfuge. Clini. Chem., 18:499-502.
13. Gijs H (2008). The role of adipose tissue dysfunction in pathogenesis of obesity related IR. Physiol. Behavior, 94:206-218.
14. Giorgio S (2006). Pathophysiology of insulin resistance. Best Pract. Res. Clini. Endocrino. Metab., 20:665-679.
15. Golzarand M, Ebrahimi-Mamaghani M, Arefhosseini SR and Ali Asgharzadeh A (2008). Effect of processed Berberis vulgaris in apple vinegar on blood pressure and inflammatory markers in type 2 diabetic patients. Iranian J. Diabetes Lipid Disorders., 8:15-20.
16. Grove H (1979). Effect of reagent PH on determination of high density lipoprotein cholesterol by precipitation with sodium phosphotungestic magnesium. Clin. Chem., 25:560-564.
17. Haiya W, Weiping J and Yuqian B (2008). Serum retinol binding protein 4 and non alcoholic fatty liver disease in patient with type 2 diabetes mellitus. Diabetes Res. Clini. Pract., 79:185-190.
18. Hjelm M and De Verdier A (1963). Determination of serum glucose by glucose oxidase method. Scand. J. Clin. Lab. Inves., 15:415-428.
19. Jerome M and Barbara A (1973). Radioimmunoassay of insulin in serum and plasma. Clin. Chem., 19:1250-1254.
20. Ji G, Zhao X, Leng L, Liu P and Jiang Z (2011). Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in Rats. Lipids Health Dis., 10:23-32
21. Jollow D, Mitchell J, Zampaglione N and Gillette J (1974). Bromobenze induced liver necrosis: Protective role of glutathione and evidence 3, 4-bromobenzen oxide as the hepatotoxic intermediate. Pharmacology., 11:151-69.
22. Jong-Yong K, Lorraine A and Polly A (2000). High fat diet induced muscle insulin resistance: Relationship to visceral mass. Am. J. Physiol. Regulatory Integrative Comp. Physiol., 279:2057-2065.
23. Jun. Y, Hanjie Z and Jianping Y (2008). Traditional Chinese medicine in treatment of metabolic syndrome. Endocr. Metab. Immune Disord. Drug Target, 8:99-111.
24. Jun-Bin S, Seon-Mee K and Geum-Ju C (2010). Elevation serum RBP4 is associated with IR in older woman. Metab. Clini. Experment, 59:118-122.
25. Khosrokhavar R, Ahmadiani A and Shamsa F (2010). Antihistaminic and anticholinergic activety of Methanolic Extract of Barberry Fruit (Berberis vulgaris) in the Guinea-Pig Ileum. J. Medicinal Plants, 9:99-105
26. Ko BS, Chio SB, Park SK, Jang JS, Kim YE and Park S (2005). Insulin sensitizer and insulinotropic action of berberine from cortidis rhizome. Biol. Pharm. Bull., 28:1431-1437.
27. Kong WJ, Zhang H and Song DQ (2009). Berberine reduces insulin resistance through protein kinase C dependant up regulation of insulin receptor expression. Metabolism, 58:109-119.
28. Lee YS, Kim WS and Kim KH (2006). Berberine is natural plant product activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin resistant states. Diabetes, 55:2256-64.
29. Li-Qin T, Wei W, LI-Ming C and Sheng L (2006). Effect of berberine on diabetes induced by alloxan and a high fat/high cholesterol diet in rats. J. Ethnopharmacology, 108:109-115.
30. Marc S (2004). Vitamin A: Absorption, Metabolism and Deficiency. Encyclopedia of Gastroenterology, pp. 616-618.
31. Maria E, Nimbe T and Armando R (2008). White adipose tissue as endocrine organ and its role in obesity. Archives Medical Res., 39:715-728.
32. Sasaki H, Lwasaki T, Kato S and Taba N (1995). High retinol binding protein ratio in non-insulin dependant DM. Am. J. Med. Sci., 310:177-182.
33. Shanmugam K, Ramakrishna C, Mallikarjuna K and Sathyavelu Reddy K (2009). Perturbation in kidney lipid metabolic profiles in diabetic rats with reference to alcoholic oxidative stress. Indian J. Nephrology., 19(3):101-106.
34. Sharma SB, Nasir A, Prabhu K, Murthy P and Dev G (2003). Hypoglycemic and hypolipidemic effect of ethanolic extract of seeds Eugenia jambolunu in alloxan induced diabetes rabbits. J. Ethnopharmacology, 85:201-206.
35. So-Young P, Yong-Woon K and Jong-Yeon K (2001). Effect of high fat diet on insulin resistance: Dietary fat versus visceral fat mass. J. Korean Med. Sci., 16:386-390.
36. Stumvoll M and Haring H (2001). Insulin resistance and insulin sensitizers. Horm. Res., 55(2):3-13.
37. Tappel L and Zalkin H (1959). Inhibition of lipid peroxidation in mitochondria by vitamin E. Arch. Biochem. Biophys., 80:333-336.
38. Timothy C, Birdsall ND, Gregory S and Kelly ND (1997). Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern. Med. Rev., 2:94-103.
39. Timothy G, Qin Y, Mattias B, Robert R (2006). Retinol binding protein 4 and insulin resistance in lean, obese and diabetic subjects. N. Engl. J. Med., 354:2552-2563.
40. Turner RC, Holman RR, Matthews D, Hockaday TD and Peto J (1979). Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism, 28(11):1086-1096.
41. Waldron A (2007). Obesity and obesity-related complications screening of adults and children in the primary care office. Northeast Florida Med., 58:21-24.
42. Watson D (1960). A simple method for the determination of serum cholesterol. Clin. Chem. Acta., 5:637-643.
43. Wei-Jia K, Hao Z and Dan S (2009). Berberine reduces insulin resistance through protein kinase c-dependant up-regulation of insulin receptor expression. Metab. Clin. Exper., 58:109-119.
44. Yang Q, Granham TE, Mody N and Preitner F (2005). Serum retinol binding protein contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436:356-369.
45. Yin J, Chen M, Tang J, Li F, Zhou L, Yang Y and Chen J (2004). Effect of berberine on glucose and lipid metabolism in animal experiment. Chinese J. Diabetes., 12:215-218.
46. Yin J, Xing H and Ye J (2008). Efficacy of berberine in patient with type 2 diabetes mellitus. Metabolism, 57(5):712-717